Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 19  •  04:00PM ET
38.36
Dollar change
+0.98
Percentage change
2.63
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y54.47% Total Holdings39 Perf Week-1.81%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM97.38M Perf Month11.56%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter30.05%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High39.60 -3.12% Perf Half Y60.21%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 104.28% Perf YTD64.01%
Active/Passive Quant Type Tagsmedical Flows% 1M1.67% Volatility1.64% 1.90% Perf Year44.75%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M8.16% ATR (14)0.77 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD16.31% RSI (14)61.23 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.36 Perf 10Y-
Expense0.54% Growth/Value SMA201.41% Flows% 3Y Rel Volume1.00 Prev Close37.38
Inverse/Leveraged Market Cap SMA5011.66% Flows% 5Y Avg Volume5.19K Price38.36
IPOOct 31, 2024 Option/ShortNo / Yes SMA20041.14% Trades Volume5,190 Change2.63%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.